We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Virtus LifeSci Biotech Clinical Trials ETF | AMEX:BBC | AMEX | Exchange Traded Fund |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.9217 | 0 | 09:09:41 |
RNS Number:1137I Ben Bailey PLC 28 February 2003 BEN BAILEY PLC ("the Company") Board Appointment At a meeting of the Board earlier today, Max Teare was appointed as a Non-executive Director of the Company. Mr Teare, aged 57, who was previously a partner at PricewaterhouseCoopers and is also a director of Bamford Mill Residents Limited, will become a member of the audit and remuneration committees. There is no further information which needs to be disclosed in accordance with paragraph 16.4 of the Listing Rules. This information is provided by RNS The company news service from the London Stock Exchange END BOAPUUBWPUPWUBR
1 Year Virtus LifeSci Biotech C... Chart |
1 Month Virtus LifeSci Biotech C... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions